Direct renin inhibition modulates insulin resistance in caveolin-1-deficient mice

Metabolism: Clinical and Experimental

Volumn 62, Issue 2, 2013, Pages 275-281

  Chuengsamarn, Somlak ^a,b   Garza, Amanda E ^a   Krug, Alexander W ^a   Romero, Jose R ^a   Adler, Gail K ^a   Williams, Gordon H ^a   Pojoga, Luminita H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

Caveolin 1; Insulin resistance; Metabolic syndrome; Renin inhibition

Indexed keywords

ALISKIREN; AMLODIPINE; CAVEOLIN 1; GLUCOSE; INSULIN; PLACEBO; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

AMIDES; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; CAVEOLIN 1; DISEASE MODELS, ANIMAL; FUMARATES; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MICE; MICE, KNOCKOUT; RANDOM ALLOCATION; RENIN; TRIGLYCERIDES;

EID: 84872676454     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.07.013     Document Type: Article

References (36)

1. E.J. Henriksen Improvement of insulin sensitivity by antagonism of the renin-angiotensin system Am J Physiol Regul Integr Comp Physiol 293 2007 R974 R980
2. S. Mottillo, K.B. Filion, and J. Genest The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis J Am Coll Cardiol 56 2010 1113 1132
3. S.I. McFarlane, M. Banerji, and J.R. Sowers Insulin resistance and cardiovascular disease J Clin Endocrinol Metab 86 2001 713 718 (Pubitemid 32207485)
4. A.H. Gradman, R. Pinto, and R. Kad Current concepts: renin inhibition in the treatment of hypertension Curr Opin Pharmacol 8 2008 120 126 (Pubitemid 351372992)
5. M. Iwai, H. Kanno, and Y. Tomono Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-A(y) mice J Hypertens 28 2010 1471 1481
6. Y.S. Kang, M.H. Lee, and H.K. Song Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice Nephrol Dial Transplant 26 2011 1194 1204
7. G. Lastra, J. Habibi, and A.T. Whaley-Connell Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression Endocrinology 150 2009 2561 2568
8. L.H. Pojoga, P.C. Underwood, and M.O. Goodarzi Variants of the caveolin-1 gene: A translational investigation linking insulin resistance and hypertension J Clin Endocrinol Metab 96 2011 E1288 E1292
9. A.W. Cohen, B. Razani, and X.B. Wang Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue Am J Physiol Cell Physiol 285 2003 C222 C235
10. R. Hnasko, and M.P. Lisanti The biology of caveolae: lessons from caveolin knockout mice and implications for human disease Mol Interv 3 2003 445 464
11. L.H. Pojoga, Z. Adamova, and A. Kumar Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice Am J Physiol Heart Circ Physiol 298 2010 H1776 H1788
12. L.H. Pojoga, J.R. Romero, and T.M. Yao Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II Endocrinology 151 2010 1236 1246
13. L.H. Pojoga, T.M. Yao, and S. Sinha Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice Am J Physiol Heart Circ Physiol 294 2008 H1258 H1265
14. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
15. A. Menachery, L.M. Braley, and I. Kifor Dissociation in plasma renin and adrenal ANG II and aldosterone responses to sodium restriction in rats Am J Physiol 261 1991 E487 E494
16. F. Younis, Y. Oron, and R. Limor Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in Cohen-Rosenthal diabetic hypertensive rats Metabolism 61 2012 164 174
17. F. Younis, N. Stern, and R. Limor Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation Metabolism 59 2010 1200 1209
18. S.C. Benson, H.A. Pershadsingh, and C.I. Ho Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity Hypertension 43 2004 993 1002 (Pubitemid 38579904)
19. J. Habibi, A. Whaley-Connell, and M.R. Hayden Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat Endocrinology 149 2008 5643 5653
20. C. Manrique, G. Lastra, and J. Habibi Nebivolol improves insulin sensitivity in the TGR(Ren2)27 rat Metabolism 2011
21. Y. Ikeda, T. Suehiro, and T. Nakamura Clinical significance of the insulin resistance index as assessed by homeostasis model assessment Endocr J 48 2001 81 86 (Pubitemid 32230388)
22. Y.F. Dong, L. Liu, and K. Kataoka Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes Diabetologia 53 2010 180 191
23. E.M. Marchionne, M.K. Diamond-Stanic, and M. Prasonnarong Chronic renin inhibition with aliskiren improves glucose tolerance, insulin sensitivity, and skeletal muscle glucose transport activity in obese Zucker rats Am J Physiol Regul Integr Comp Physiol 302 2012 R137 R142
24. M. Ozata, I.C. Ozdemir, and J. Licinio Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects J Clin Endocrinol Metab 84 1999 3686 3695 (Pubitemid 30645226)
25. M. de Courten, P. Ferrari, and M. Schneider Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension Eur J Clin Pharmacol 44 1993 457 462 (Pubitemid 23164996)
26. P. Ferrari, D. Giachino, and P. Weidmann Unaltered insulin sensitivity during calcium channel blockade with amlodipine Eur J Clin Pharmacol 41 1991 109 113
27. E.E. Daniel, T. Eteraf, and B. Sommer The role of caveolae and caveolin 1 in calcium handling in pacing and contraction of mouse intestine J Cell Mol Med 13 2009 352 364
28. J. Li, L. Zhao, and I.K. Ferries Skeletal phenotype of mice with a null mutation in Cav 1.3 L-type calcium channel J Musculoskelet Neuronal Interact 10 2010 180 187
29. D.L. Feldman, L. Jin, and H. Xuan Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats Hypertension 52 2008 130 136
30. B.H. Oh, J. Mitchell, and J.R. Herron Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension J Am Coll Cardiol 49 2007 1157 1163 (Pubitemid 46400330)
31. T. Kushiro, H. Itakura, and Y. Abo Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension Hypertens Res 29 2006 997 1005 (Pubitemid 46206586)
32. W. Krone, M. Hanefeld, and H.F. Meyer Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic syndrome J Hum Hypertens 25 2011 186 195
33. A.H. Gradman, R.E. Schmieder, and R.L. Lins Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients Circulation 111 2005 1012 1018 (Pubitemid 40354519)
34. A. Stanton, C. Jensen, and J. Nussberger Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren Hypertension 42 2003 1137 1143 (Pubitemid 37549068)
35. A.A. Toye, J.D. Lippiat, and P. Proks A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice Diabetologia 48 2005 675 686 (Pubitemid 40591223)
36. R.A. Rizza Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy Diabetes 59 2010 2697 2707